Đang chuẩn bị liên kết để tải về tài liệu:
Infection risks in multiple myeloma: A systematic review and meta-analysis of randomized trials from 2015 to 2019
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Patients with multiple myeloma (MM) remain at an increased risk of infection due to the disease process, as well as the ensuing treatments. We performed a systematic review to evaluate the monthly risk of grade III/IV infection, pneumonia, and neutropenia in patients with myeloma enrolled in randomized clinical trials (RCTs). |